ROSELAND, N.J., May 13, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, today announced that it will host a conference call at 8:30 AM Eastern Time on Thursday, May 16th, 2024, to discuss the company’s financial results for the first quarter ended March 31, 2024, as well as the company’s corporate progress and other developments. The conference call will be available via telephone by ...

PRC Alliance Pain Relief Center operates 8 locations across central Florida Dr. Bakshi reports 100% success performing Epidural Steroid Injection (ESI) procedures during evaluation period ROSELAND, N.J., April 03, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced that it has commenced sales of CompuFlo® Epidural disposables into PRC Alliance Pain Relief Center at Ormond B ...

Company Participants Conference Call Participants Operator It is now my pleasure to turn the floor over to your host, David Waldman, Investor Relations of Milestone Scientific. Sir, the floor is yours. Good morning and thank you for joining Milestone Scientific's 2023 year-end financial results conference call. On the call with us today are Arjan Haverhals, Chief Executive Officer; and Keisha Harcum, Vice President of Finance and Milestone Scientific. Company issued a press release today, April 1, 2024, con ...

| UNITED STATES | | | --- | --- | | SECURITIES AND EXCHANGE COMMISSION | | | Washington, D.C. 20549 | | | FORM 10-K | | | (Mark One) | | | ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | | | For the fiscal year ended December 31, 2023 | | | Or | | | ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | | | For the transition period from to | | | Commission file number 001-14053 | | | Milestone Scientific Inc. | | | (Exact name o ...

ROSELAND, N.J., March 14, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced that it has commenced sales of CompuFlo® Epidural disposables to Omaha Pain Physicians, a comprehensive medical pain management center in Omaha, NE. Omaha Pain Physicians is focused on treating patients with acute and chronic pain. Adoption of the technology by this clinic follows a successful eva ...

ROSELAND, N.J., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announces it has commenced direct sales of its STA Single Tooth Anesthesia System® (STA) with Meridian Endo & Perio, a large endodontics, periodontics and implant dentistry practice with three offices in Wisconsin. Dr. Lisa Teel, periodontist and implant surgeon with Meridian Endo and Perio, stated, "Our pra ...

ROSELAND, N.J., Jan. 16, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today provided the following letter to shareholders from the Company's CEO, Arjan Haverhals, including updates regarding commercialization of the CompuFlo® technology and initial reimbursements of CompuFlo by commercial payors and Medicare: To our valued shareholders, While we recognize commercializing a new medic ...

At the same time, we continue to maintain a lean operating structure and we are laser-focused on driving shareholder value. We look forward to providing further updates as developments unfold. I'd like to thank you for joining the call today. And at this point, we would like to open the call up to questions. Operator? Question-and-Answer Session Operator Thank you very much. At this time,, we will be conducting a question-and-answer session. [Operator Instructions] Your first question is coming from Anthony ...

DOCUMENTS INCORPORATED BY REFERENCE None 1 | UNITED STATES | | | | --- | --- | --- | | SECURITIES AND EXCHANGE COMMISSION | | | | Washington, D.C. 20549 | | | | FORM 10-Q | | | | ☒QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | | (Mark One) | | For the quarter ended September 30, 2023 | | | | ☐TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | | | | For the transition period from to | | | | Commission file number 001-14053 | | ...

Milestone Scientific Inc. (NYSE:MLSS) Q2 2023 Earnings Conference Call August 15, 2023 8:30 AM ET David Waldman - Investor Relations Peter Milligan - Chief Financial Officer Anthony Vendetti - Maxim Group Operator I will now turn the conference over to your host, Mr. David Waldman, Investor Relations. David, you may begin. Good morning, and thank you for joining Milestone Scientific's second quarter 2023 financial results conference call. On the call with us today are Arjan Haverhals, Chief Executive Office ...